These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 12765501

  • 1. Hepatitis C transmission and HIV post-exposure prophylaxis after needle- and syringe-sharing in Australian prisons.
    O'Sullivan BG, Levy MH, Dolan KA, Post JJ, Barton SG, Dwyer DE, Kaldor JM, Grulich AE.
    Med J Aust; 2003 Jun 02; 178(11):546-9. PubMed ID: 12765501
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A syringe exchange programme in prison as prevention strategy against HIV infection and hepatitis B and C in Berlin, Germany.
    Stark K, Herrmann U, Ehrhardt S, Bienzle U.
    Epidemiol Infect; 2006 Aug 02; 134(4):814-9. PubMed ID: 16371183
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Molecular epidemiology of HIV, HBV, HCV, and HTLV-1/2 in drug abuser inmates in central Javan prisons, Indonesia.
    Prasetyo AA, Dirgahayu P, Sari Y, Hudiyono H, Kageyama S.
    J Infect Dev Ctries; 2013 Jun 15; 7(6):453-67. PubMed ID: 23771289
    [Abstract] [Full Text] [Related]

  • 10. Clean switch: the case for prison needle and syringe programs.
    Chu S.
    HIV AIDS Policy Law Rev; 2009 Dec 15; 14(2):5-19. PubMed ID: 20225504
    [Abstract] [Full Text] [Related]

  • 11. Continued transmission of hepatitis B and C viruses, but no transmission of human immunodeficiency virus among intravenous drug users participating in a syringe/needle exchange program.
    Månsson AS, Moestrup T, Nordenfelt E, Widell A.
    Scand J Infect Dis; 2000 Dec 15; 32(3):253-8. PubMed ID: 10879594
    [Abstract] [Full Text] [Related]

  • 12. Acquiring hepatitis C in prison: the social organisation of injecting risk.
    Treloar C, McCredie L, Lloyd AR, HITS-p investigators.
    Harm Reduct J; 2015 Apr 24; 12():10. PubMed ID: 25903401
    [Abstract] [Full Text] [Related]

  • 13. [Transmission of infectious diseases during imprisonment--results of a study and introduction of a model project for infection prevention in Lower Saxony].
    Keppler K, Stöver H.
    Gesundheitswesen; 1999 Apr 24; 61(4):207-13. PubMed ID: 10408149
    [Abstract] [Full Text] [Related]

  • 14. Human immunonodeficiency virus, hepatitis B virus and hepatitis C virus: sero-prevalence, co-infection and risk factors among prison inmates in Nasarawa State, Nigeria.
    Adoga MP, Banwat EB, Forbi JC, Nimzing L, Pam CR, Gyar SD, Agabi YA, Agwale SM.
    J Infect Dev Ctries; 2009 Aug 30; 3(7):539-47. PubMed ID: 19762972
    [Abstract] [Full Text] [Related]

  • 15. Hepatitis B and C in New South Wales prisons: prevalence and risk factors.
    Butler TG, Dolan KA, Ferson MJ, McGuinness LM, Brown PR, Robertson PW.
    Med J Aust; 1997 Feb 03; 166(3):127-30. PubMed ID: 9059433
    [Abstract] [Full Text] [Related]

  • 16. Prevalence and epidemiological characteristics of inmates diagnosed with infectious diseases living in a region with a high number of prisons in São Paulo state, Brazil.
    do Nascimento CT, Pena DZ, Giuffrida R, Bandeira Monteiro FN, da Silva FA, Flores EF, Prestes-Carneiro LE.
    BMJ Open; 2020 Sep 06; 10(9):e037045. PubMed ID: 32895275
    [Abstract] [Full Text] [Related]

  • 17. [Post-exposure prevention after occupational exposure to HBV, HCV and HIV].
    Sarrazin U, Brodt R, Sarrazin C, Zeuzem S.
    Orthopade; 2004 Feb 06; 33(2):231-44. PubMed ID: 15035265
    [Abstract] [Full Text] [Related]

  • 18. Prevalence of HIV, hepatitis B, and hepatitis C antibodies in prisoners in England and Wales: a national survey.
    Weild AR, Gill ON, Bennett D, Livingstone SJ, Parry JV, Curran L.
    Commun Dis Public Health; 2000 Jun 06; 3(2):121-6. PubMed ID: 10902255
    [Abstract] [Full Text] [Related]

  • 19. [Seroprevalence of hepatitis C virus infection at the time of entry to prison in the prison population in the north-east of Spain].
    Martín Sánchez V, Ferrer Castro V, Pallas Álvarez JR, Alonso Herrero LE, Andrés Honorato M, Coterillo González MJ, García Marcos LS, González Márquez J, Hernández Alonso I, LLanos Gallegos M, Mallada García E, Martínez Martínez ML, Morillo Pérez M, Pérez Martínez I, Valles Martínez J.
    Rev Esp Salud Publica; 1998 Jun 06; 72(1):43-51. PubMed ID: 9477715
    [Abstract] [Full Text] [Related]

  • 20. Prevalence and determinants of anti-HCV seropositivity and of HCV genotype among intravenous drug users in Berlin.
    Stark K, Schreier E, Müller R, Wirth D, Driesel G, Bienzle U.
    Scand J Infect Dis; 1995 Jun 06; 27(4):331-7. PubMed ID: 8658065
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.